The DEA is in the middle of potentially rescheduling cannabis, a move that would mark the biggest federal shift on marijuana in decades. So why, in the middle of this seismic policy moment ...

The agency's sluggish processing of cultivation applications (mandated by the Medical Marijuana and Cannabidiol Research Expansion Act directly hinders MMJ's ability to proceed. Catch-22: The DEA ...

The DEA may be close to reaching a decision on rescheduling marijuana to recognize the medical benefits. The DEA spokesman Russ Baer said no determination has been made yet on rescheduling pot, but ...

The DEA is proposing to increase the amount of marijuana that can be legally grown for research by 30% in 2020, a promising sign for cannabis advocates who have long insisted the plant has healing ...

Read Also: DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On In his ruling, Mulrooney acknowledged allegations of improper conduct ...

2025 / The House Oversight Committee hearing on federal marijuana policy in 2020 had brought to light significant bipartisan frustration with the Drug Enforcement Administration's (DEA ...

An administrative law judge nixed a DEA hearing on the proposed rescheduling of marijuana set to take place next week, pushing the hearing well into President-elect Donald Trump's next administration.

The agency's sluggish processing of cultivation applications (mandated by the Medical Marijuana and Cannabidiol Research Expansion Act directly hinders MMJ's ability to proceed. Catch-22: The DEA ...